National Health and Wellness Commission issued a document: on-site inspection of equipment enterprises.

Recently, the State Health and Health Commission Comprehensive Supervision Bureau issued a message that the medical and health industry comprehensive supervision and supervision training mobilization will be held in Beijing, the Deputy Director of the National Health and Health Commission Li Bin stressed that the National Health and Health Commission will work with relevant departments to enhance the effectiveness of supervision, promote the health care industry comprehensive supervision institutionalization, standardization, normalization.
At the same time, the State Health and Welfare Commission's General Supervision Bureau issued the "Announcement on the implementation of the 2020 medical and health industry comprehensive supervision and inspection of the collection of clues on the issue of the issue" shows that the main collection of commercial bribery in the field of medicine and other unfair competition, medical institutions illegal practice, illegal publication of medical advertising, medical insurance fixed-point medical institutions do not regulate the use of medical insurance funds, public medical institutions have not implemented collection and cancellation of the increase and other issues clues.
the inspection team will conduct spot checks during field inspections, which will be collected from 18 September to 31 October this year.
addition, on September 17th the State Health Insurance Administration announced that the Supreme People's Court and the State Health Insurance Administration had signed a memorandum of cooperation to establish a mechanism for the exchange and sharing of information on cases of commercial bribery in medicine.
main content of the project is to establish a regular notification system of commercial bribery cases in the field of medicine, and actively expand the use of judicial results in commercial bribery cases in the field of pharmaceutical prices and recruitment.
As early as July 24, the National Health and Safety Commission issued the "National Health and Health Commission Office on the issuance of the 2020 medical industry style construction work special action plan notice" requirements, to crack down on medical institutions practitioners to collect kickback violations.
To carry out special governance to combat the collection of rebates by medical institution practitioners, to investigate and punish the acts of medical institutions and their employees who use their practice to obtain improper benefits and receive kickbacks, and to focus on examining the kickbacks given by medical institution practitioners in accepting pharmaceutical products such as medicines, medical devices, medical hygiene materials, etc., and to operating enterprises or distribution personnel in various names and forms.
seriously investigate and punish the distribution personnel of pharmaceutical products production and operation enterprises for illegal marketing behavior in medical institutions.
to examine medical institutions outpatient clinics, inpatient departments, pharmacies and other areas of the production of pharmaceutical products, operating enterprises or distribution personnel illegal sales of drugs, medical equipment to medical personnel, business negotiations.
to change the pay structure of doctors it is understood that corruption between hospitals and pharmaceutical companies, mainly drugs and medical equipment, medical supplies and other rebates.
Jilin University's special research project on the construction of clean government has published research shows that according to the field of entrusted power exercise, medical corruption can be divided into the selection of personnel, financial management, infrastructure logistics, tender procurement, affiliated enterprises, foreign cooperation, medical insurance, medical ethics in the field of a total of 8 types of corruption.
according to the nature of corruption in the exercise of delegated power, medical corruption can be divided into two types: explicit corruption and invisible corruption, the former through the abuse of power directly to receive property, the latter through the abuse of delegated power indirectly, hidden to obtain private benefits.
, medical corruption is concentrated in the "cross-sectional", "inside and outside interweaving" two characteristics.
The relevant researchers of the Chinese Academy of Social Sciences published the article "Research on the Law and Policy Governance of Commercial Bribery in Pharmaceutical Enterprises", which shows that the main forms of medical bribery in hospitals include kickbacks, hospital fees and other forms of commercial bribery, among which rebates to medical personnel are an important issue in the field of corruption in the purchase and sale of medicines.
this issue, there is a view in the industry that medical staff receive rebates because of the unreasonable pay structure caused by their low income.
to this, researchers from Tsinghua University's Institute of Hospital Management conducted a survey on the salaries of doctors in public hospitals in Sanming City, and the annual salary system is one of the ways adopted by Sanming, and since the implementation of the reform of the annual salary system, the per capita income of doctors in public hospitals in Sanming City has increased significantly, from 2012. 704,000 yuan increased to 999,000 yuan in 2013, and then rose steadily, reaching 134,600 yuan in 2017, 1.91 times more than in 2012.
doctors' income increased, hospital drug and supplies inspection income decreased significantly.
data show that since the implementation of a series of reforms, such as medicine, health care and remuneration, the proportion of drug, supplies and inspection income in public hospitals at or above the county level in Sanming City has fallen from 60.06 percent in 2011 to 33.16 percent in 2016, and the proportion of medical income has increased from 39.94 percent in 2011 to 66.84 percent in 2016.
The two-vote system to change the industry to solve the problem of supplies rebates, the national level has a continuous policy landing, two-vote system, volume procurement, DRG and so on, are having a significant impact on the industry, including national-level belt procurement is about to land, at present, many provinces have been collecting the product data of various enterprises.
as of April 30, 2020, more than 25 provinces, municipalities and autonomous regions nationwide have introduced a "two-vote system" policy for supplies, according to a prospecto issued by an armed enterprise.
industry analysis that the important purpose of the two-vote system is to compress the circulation of the price of moisture, for the problem of inflated prices of consumables, to promote the price reduction of consumables, compression of the space for gold sales.
same time, a large number of dealers have been affected.
published an article in the Chinese market journal analyzing the impact of the two-vote system from both the pharmaceutical industry and the pharmaceutical business.
For upstream industries, that is, production enterprises, two-vote system to clean up the internal supply chain process, sales channels gradually flattened, ticketing companies gradually withdraw from the historical stage, from the way of floor price insension to the commission return model transition, to a certain extent, increased the economic benefits of pharmaceutical industry enterprises, improve drug agency costs, at this stage, pharmaceutical industry enterprises' financial income and tax amount relationship is positive.
Second, the two-vote system makes pharmaceutical industry enterprises from the form of low-cost insaling to commission rebate insaling method, can urge pharmaceutical enterprises to return part of the agency fees, to avoid irregularities, in this case, pharmaceutical industry enterprises financial managers are faced with how to regulate the reasonable handling of high opening difference costs of the work challenge.
for the commercial sector, the two-vote system changed the mode of advance funds for agents to apply the medical insurance system, to a certain extent, improve the efficiency of work, but also for small and medium-sized pharmaceutical commercial enterprises to bring the risk of elimination.
from the dealer's point of view, the implementation of the two-vote system, the removal of irregular circulation enterprises, increased the space for sales, standardized the process of drug sales, industry concentration has been enhanced.
the sharp reduction of agents, the high-opening model adopted by pharmaceutical industry enterprises has brought greater pressure on pharmaceutical commercial enterprises to advance funds.
some hospitals can rely on their own advantages to extend the payment cycle, but also increased the proportion of accounts receivable of pharmaceutical commercial enterprises, the financial pressure increased sharply.
.